WuXi AppTec and Yuheng Pharma Forge Strategic Partnership, Boosting Prospects for Biotech Firms
Work | Christ Healing the Sick
Author |Mathieu Ignace Van Brée
Illustrated History of Healthcare | Issue 20180527
In Issue 20180401 of "Medical History in Pictures," we previously highlighted that the history of medical progress is essentially a history of human development. In the earliest human civilizations, both the East and the West gave rise to "ancient medicine." However, as human understanding of the world at that time was primarily based on experience and observation, phenomena such as disease and death could not yet be interpreted from a scientific perspective. Consequently, medicine was closely associated with "theology" and "divination." This illustration reflects this historical context.
SF Express’s annual report discloses that its pharmaceutical transportation network currently covers 132 prefecture-level cities across China, basically encompassing most key regions nationwide. It provides services including ambient-temperature transport, less-than-truckload (LTL) shipping, express delivery, commercial distribution, and warehousing. SF Holding’s cold-chain logistics network covers 104 cities and surrounding areas, comprising three pharmaceutical cold storage facilities and 12 pharmaceutical trunk lines.
Overall, the industrialization and scaling of denture manufacturing have significantly propelled the development of the dental industry, leading to more uniform quality in denture production while enhancing standardization and regulatory compliance. VCBeat has reviewed the current state of the denture (commonly known as false teeth) industry to identify potential future trends for denture manufacturers.
The overall positive momentum for biotech companies is an irreversible trend. But what are the drivers behind the limit-up gains of WuXi AppTec and Yuheng Pharmaceutical? Next, VCBeat will provide a brief analysis from macro to micro perspectives.
Xiaomi Corporation primarily focuses its strategic layout on an ecosystem centered around smart hardware and content; Shunwei Capital mainly pursues a broad strategic investment portfolio built around the “hardware + software + services” model; Kingsoft Software emphasizes Kingsoft Cloud, with its strategic layout primarily reflected in cloud services.
VCBeat believes that the health and medical big data industry has officially entered the phase of integration under the “national team.”
Saturday:Micro-Doctor's Growth Path Under Super Variables
We revisited more than 350 articles about WeDoctor to map out its development trajectory and growth drivers.
On May 20, jointly initiated by Wang Longde, Wang Chen, and Ning Guang, Academicians of the Chinese Academy of Engineering; Ge Junbo and He Jie, Academicians of the Chinese Academy of Sciences; and Huo Yong, Director of the Department of Cardiology and Heart Center at Peking University First Hospital, was establishedChina County Hospital Presidents Alliance, facilitating the establishment of five major centers—stroke, chest pain, respiratory, metabolic, and oncology—at primary healthcare institutions.
May 20,China's First Alipay Future PharmacySettling in Henan Zhengzhou Zhang Zhongjing Pharmacy. Compared with traditional pharmacies, the most convenient function of future pharmacies lies in: just scan the code with your mobile phone to realize identity information recognition, social security card binding, home medical equipment rental, online payment settlement, remote consultation, installment purchase of medicines and membership management and many other functions.
On the evening of May 22,WuXi BiologicsThe company issued an announcement stating its plan to invest S$80 million (approximately RMB 380 million) to establish a modern biopharmaceutical production facility in Singapore. This marks WuXi Biologics’ second overseas production base following its investment in Ireland, and also represents its first new production facility in Asia outside of China.
May 23, in 2018TencentAt the “Cloud + Future” Summit, Tencent’s TI Matrix, positioned as the “intelligent operating system” of the digital world, was officially launched. The innovative approach of “Tencent Miying” has opened up rich possibilities for a new generation of healthcare-focused super brains, while also charting the development direction for China’s new generation of open innovation platforms in artificial intelligence.
On May 23, information from the website of the National Medical Products Administration (NMPA) indicated that the approval status of the marketing application for Albuvirtide, a Class 1 new drug independently developed by Frontier Biotechnologies, has been updated to “Approval Completed – Awaiting Certificate Issuance.”. The world's firstLong-Acting Anti-HIV Drug Albuvirtide Is Set to Hit the Market.
On May 24, the world-renownedHHMI(The Howard Hughes Medical Institute) announced the list of its 19 newly selected investigators.Zhang Feng, Zhang Yuanhao, Wang MengThree prominent Chinese-American scholars have been elected as HHMI Investigators. As Dr. David Clapham, Vice President and Chief Scientific Officer of HHMI, stated, “These scientists know how to use skill, ingenuity, and courage to answer difficult and interesting questions.”
Liu Hao, Haoyue Capital
Healthcare investment funds are beginning to pursue differentiated competition by selecting a niche sector and expanding their layout across the upstream and downstream value chains, thereby generating strong synergies. A recent phenomenon is “Find vs. Found.” In certain investment areas, there is significant potential for high returns, but suitable investment targets are scarce; as a result, funds are assembling their own teams and establishing companies. This is also a very interesting trend. (Source: VCBeat）
According to a Kyodo News report on May 24, a research team led by Professor Koji Fukunaga (Neuropharmacology) at Tohoku University in Japan announced on the 22nd that they had elucidated the pathogenesis of ATR-X syndrome, a refractory disorder causing severe intellectual disability, and discovered that administration of a specific amino acid can alleviate symptoms. This marks the first identification worldwide of a candidate therapeutic drug for this condition. The findings were published online on the 21st in a U.S. medical journal. (Source: VCBeat)
Parkinson’s Disease Medications May Be Effective Against Tuberculosis
Researchers from the Francis Crick Institute, Newcastle University, and GlaxoSmithKline have identified a link between Parkinson’s disease and tuberculosis. An article published on May 22 in the EMBO Journal, titled “LRRK2 is a negative regulator of Mycobacterium tuberculosis maturation in macrophages,” offers a potential explanation for the etiology of Parkinson’s disease and suggests that medications used to treat Parkinson’s may also be effective against tuberculosis. (Source: genengnews.com)
Tumor Suppressor Genes Are Shortened by 3' UTR Truncation
Researchers say they have uncovered new information that more accurately explains how tumors grow in the body. The research team, led by scientists at the University of Texas Medical Branch (UTMB), found that the loss of a segment of mRNA capable of transforming normal cells into cancer cells actually inhibits tumor formation by blocking the body’s ability to do so. According to the researchers, this discovery could fundamentally change the way medical science studies tumorigenesis. (Source: genengnews.com)
Remote Interpretation Video Application Enabled, Greatly Improving Doctor-Patient Communication Efficiency
Southcoast Health recently launched a remote interpretation application that connects the hospital with qualified medical interpreters to support its population health management programs. Serving as intermediaries between patients and physicians, interpreters help guide patients through medical procedures, alleviate their fears—particularly among those with limited English proficiency—facilitate understanding of treatment plans, and enhance the efficiency and accuracy of doctor-patient communication. (Source: healthcareitnews)
Analysys: "White Paper on Internet-Based Family Health Management in China"
Healthcare expenditure has been rising year by year, with rigid growth in the pressure on medical insurance. Under the "Healthy China 2030" framework, public health awareness has improved, and health management is gradually extending from hospitals and communities into households, driving health management providers to transition from single-service offerings to diversified, comprehensive services.
National Medical Products Administration: Annual Report on National Adverse Event Monitoring of Medical Devices (2017)
In accordance with the Regulations on the Supervision and Administration of Medical Devices and the Administrative Measures for the Monitoring and Re-evaluation of Adverse Events Involving Medical Devices (Trial), and to comprehensively reflect the status of medical device adverse event monitoring in China in 2017, the former China Food and Drug Administration organized the National Center for ADR Monitoring to conduct a comprehensive analysis and summary of the monitoring information on adverse events involving medical devices in 2017, thereby compiling the Annual National Report on Medical Device Adverse Event Monitoring (2017).
For more content, please visit the VCBeat knowledge base!
